Friedrich Scheiflinger

City:

Wien

Country:

Austria

Published Applications:

Last publication date:

2021-06-24

Top Assignees for applications by Friedrich Scheiflinger

The entities that hold a legal rights for patent applications filed by inventor Scheiflinger Friedrich:

BAXALTA INCORPORATED 3 Bannockburn, IL United States
Baxalta GmbH 2 Zug, Switzerland
Katholieke Universiteit Leuven 1 Leuven, Belgium
Takeda Pharmaceutical Company Limited 1 Osaka, Japan
BAXALTA GMBH 1 Glattpark (Opfikon), Switzerland

Recent patent applications by Scheiflinger Friedrich

Friedrich Scheiflinger from Wien, AT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-06-24

US20210187105A1

Human necessities

COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND GLUCOCORTICOIDS

#2 | 2018-10-04

US20180280501A1

Human necessities

COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND GLUCOCORTICOIDS

#3 | 2018-04-26

US20180110842A1

Human necessities

COMPOSITIONS COMPRISING ADAMTS13 FOR USE IN METHODS FOR THE RECANALIZATION OF OCCLUDED BLOOD VESSELS IN AN INFARCTION

#4 | 2017-02-23

US20170049885A1

Human necessities

COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND CHEMOTHERAPEUTICS

#5 | 2015-09-10

US20150250873A1

Human necessities

COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND GLUCOCORTICOIDS

#6 | 2015-06-11

US20150160235A1

Physics

Anti-MIF immunohistochemistry

#7 | 2015-03-12

US20150071942A1

Human necessities

COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND CHEMOTHERAPEUTICS

#8 | 2014-09-25

US20140287443A1

Physics

Characterization of CHO-MIF gene and protein, and use thereof

#9 | 2014-09-04

US20140248638A1

Physics

OxMIF as a diagnostic marker

InventorID:

896035 ⎘